Sponsor:
Ardeshir Rastinehad
Code:
NCT04599218
Conditions
Prostate Disease
Elevated Prostate Specific Antigen
Family History of Prostate Cancer
Positive Digital Rectal Exam
Prostate Cancer
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Prostate Biopsy
MR US Fusion Guided Prostate Biopsy
MR/TRUS Fusion Guided Prostate Biopsy
Brief summary:
Conditions
Prostate Disease
Elevated Prostate Specific Antigen
Family History of Prostate Cancer
Positive Digital Rectal Exam
Prostate Cancer
Study ID
NCT04599218
Start date
Aug 21, 2020
Status verified date
Feb, 2024
Completion date
Jan 15, 2026
Anticipated
Primary completion date
Oct 15, 2025
Anticipated
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
1586 participants
Anticipated
Intervention Model
Single group
Primary purpose
Diagnostic
Arms
experimental: Males with Prostate Cancer
Interventions
Prostate Biopsy
MR US Fusion Guided Prostate Biopsy
MR/TRUS Fusion Guided Prostate Biopsy
Primary outcome measure
Central contacts
Locations
The Smith Institute for Urology
Recruiting
Lake Success, New York, United States, 11042
Contacts
Peter Tricarico
ptricarico1@northwell.eduThe Smith Institute for Urology at Lenox Hill
Recruiting
New York, New York, United States, 10022
Contacts
Manhattan Eye, Ear, and Throat Hospital (MEETH)
Recruiting
New York, New York, United States, 10065
Contacts
Sponsor
Ardeshir Rastinehad
Last update posted
Feb 2, 2024
Last verified
Feb, 2024
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Ardeshir Rastinehad on 2024-02-02.